In both murine and human systems, incubation of fresh lymphocytes alone in lectin-free lymphokine preparations rich in interleukin 2 (IL-2) results in the development of lytic activity against fresh autologous and allogeneic solid tumor cells (1) (2) (3) (4) . The human lymphokine-activated killer cells (LAK) represent a cytotoxic system distinct from conventional cytotoxic T lymphoid cells and natural killer (NK) cells based on a variety of characteristics including kinetics of activation, target cell specificity, the stimulus responsible for activation, and phenotype of the precursor and effector cells (2) (3) (4) (5) .
While we have consistently observed LAK activation only after incubation of PBL with cytokine preparations containing IL-2, it was possible that due to the heterogeneous nature of our standard lectin-free IL-2 preparations, other lymphokine(s) or monokine(s) could be responsible or could act synergistically with IL-2 to activate LAK. Therefore, this study was undertaken to define the cytokine(s) responsible for the direct activation of nonlytic PBL into LAK cells. The results show that the LAK stimulus adsorbs significantly to IL-2-dependent murine cell lines, as does all detectable IL-2 activity . IL-2 preparations from both the Jurkat leukemia line (6, 7) , and from the MLA-144 line (8) purified to apparent molecular homogeneity were both highly active in the generation of LAK. Anti-Tac antibody that recognizes the IL-2 receptor (9, 10) was observed to block LAK activation . Purified preparations of IL-1, migration inhibition factor (MIF), interferon (IFN), and IFN-y produced by recombinant DNA technology were all negative for activation of LAK. Thus, we conclude that IL-2 alone directly activates LAK precursors into cytolytic effector cells that are efficient in lysing single-cell suspensions of noncultured solid tumor cells in a 4-h chromium-release assay.
Materials and Methods
IL-2 Preparations and Purification. Lymphokine supernatants rich in IL-2 activity were prepared by stimulation of human PBL with phytohemagglutinin (PHA) as described in detail previously (11, 12) . The crude IL-2 preparation was then partially purified accord-1356
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IL-2 from the Jurkat human leukemia line (14) was obtained after stimulation with PMA and PHA as described (15) . Jurkat IL-2 was purified using adsorption to an anti-IL-2 affinity column using a murine monoclonal antibody (16) . The IL-2 that was eluted from the column appeared homogeneous by two-dimensional gel electrophoresis using isoelectric focusing (IEF) in the first dimension, followed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) (16) .
IL-2 purified from the cultured supernatant of the Gibbon ape MLA-144 was the generous gift of Dr. Louis Henderson and Dr . Harvey Rabin, Frederick Cancer Research Center, Frederick, MD . MLA IL-2 was purified to apparent molecular homogeneity by trimethylsilane-controlled pore glass adsorption, followed by reverse-phase high performance liquid chromatography as described by Henderson et al . (17) . All lymphokine preparations were tested for IL-2 content by their ability to stimulate ['H]thymidine uptake in a 48-h assay using human IL-2-dependent cell lines as previously described (11, 12) .
Adsorption of Human IL-2 by IL-2-dependent Lymphocyte Lines. IL-2-addicted murine cells (line 53) were harvested, washed free of culture medium, and incubated at 37°C for 2 h in RPMI 1640 medium (5 X 106 cells/ml) containing 10% human AB serum (CM) . These cells were then washed twice in serum-free RPMI 1640 and divided into aliquots of 5 X 10' each . 1 ml of a dilution of human IL-2 in RPMI 1640 was added to each aliquot of line 53 cells, and adsorption performed at room temperature for 2 h with occasional mixing . This first adsorption was terminated by centrifugation of the cells, after which the supernatant was aspirated and added to a second 5 X 10' cell pellet for an additional adsorption step .
Preparation and Purification of Other Cytokines. Human IL-1 was prepared from FicollHypaque-purified PBL by culturing for 48 h at 3 X 10 6/ml in minimal essential medium containing 5% pooled normal human serum and 10 jLg/ml Escherichia coli lipopolysaccharide (LPS) (Difco Laboratories Inc ., Detroit, MI) . IL-1 was purified by hollow fiber diafiltration and ultrafiltration, followed by sucrose gradient IEF, and activity was determined in the mouse thymocyte [ 5 H]thymidine incorporation assay as previously described (18) . The IEF-purified material expressed biological activity at 0 .1% (vol/vol) and contained no IL-2 activity .
Two preparations of leukocyte MIT devoid of IL-2 were the generous gift of Dr . H . Verheul, Organon, OSS, Holland (19) and represent the supernatant of human lymphobastoid cell line cultures CP 82004 and 82DB02 . The specific MIF activity was 36 and 17 U/mg, respectively . IFN-y produced by recombinant DNA technology was generously provided by Genentech, Inc ., San Francisco, CA . Purified alpha and gamma IFN produced from PBL was purchased from Interferon Sciences, Inc ., New Brunswick, NJ .
LAK Activation and Testing for Cytotoxicity . PBL at 1 X 10 6/ml were cultured in CM containing 10% human AB serum (10 ml maximum) for 4-6 d at 37°C with various dilutions of IL-2 or other factors in Costar 3050 flasks (Costar, Cambridge, MA) . The cells were then harvested, washed twice in CM, counted, and used as effector cells for lysis of NK-resistant, cryopreserved, uncultured sarcoma cells. These cells were composed of a minimum of 93% tumor cells as judged by cytological analysis (3) . Lysis was tested in a 4-h 51 Cr-release assay at a variety of effector/target ratios and data is reported as either percent specific lysis (2) or in terms of lytic units (LU), defined as the number of effector cells required to cause a 33 .3% lysis of 5 X 10 5 tumor cells .
Results and Discussion
LAK Activation Signal(s) Copurfies with IL-2 During Protein Purification Procedures. Since LAK stimulation always occurred when IL-2-rich lymphokine supernatants were used, our initial approach to dissection of the signal(s) responsible for LAK activation was to apply the standard IL-2 purification procedure and follow in parallel the separation of IL-2 and LAK activation factor(s). We consistently observed LAK activation using IL-2-enriched fractions from ammonium sulfate precipitation and DEAE anion exchange chromatography. Furthermore, we previously reported (20) that these two activities copurified during ACA 54 Ultragel separation, confirming that IL-2 and the LAK stimulatory signal(s) share similar physical properties of molecular size (used in ACA Ultragel separation) and ionic/hydrophobic characteristics (used in DEAE anion exchange chromatography) .
LAK Sti)nulatory Signal Adsorbs to IL-2-dependent Cells. Fig. 1 displays the results from one of three adsorption experiments in which the lectin-free, partially purified IL-2 and the LAK stimulatory signal(s) were consistently adsorbed by IL-2-dependent cell lines. Adsorption was effective in removing all IL-2 activity and in causing a 4-16-fold decrease in the generation of LAK activity measured in LU.
LAK Activation is Inhibited by Monoclonal Anti-IL-2-receptor Antibodies. The monoclonal antibody, anti-Tac, has been reported to recognize the IL-2 receptor and block IL-2 binding (9, 10). When dilutions of anti-Tac ascites (generously provided by Dr. Thomas Waldmann, Metabolism Branch, National Cancer Institute) were added to the initiation of LAK culture on day 0 at the same time as the partially purified lectin-free IL-2, a dose-dependent inhibition of LAK activation was observed (Table I ). In contrast, addition of anti-Tac to the 4-h cytotoxicity test had no effect, even at the 1 :500 dilution . Therefore, the antiTac antibody appeared to inhibit the activation phase of LAK, implying that the binding of IL-2 to its receptors is an obligatory step in LAK cell activation .
Purified IL-2 Activates LAK. The preceding data provides very strong yet circumstantial evidence that LAK cells are stimulated directly by IL-2. To test this in a conclusive manner, two preparations of IL-2 purified to molecular homogeneity were used . Both the Jurkat-derived (16) and MLA-144-derived IL-2 were highly stimulatory for LAK over a very broad concentration range (Table  II) . Though we have confirmed that highly purified IL-2 directly activates LAK cells, IL-2 may not be exclusive in this property . Therefore, we have acquired and tested a number of other human cytokines that are able to stimulate mononuclear cell functions . IL-1, MIF, and a variety of IFN preparations tested at several log-fold dilutions surrounding the optimal dose (optimal dose determined independently for each cytokine preparation; data not shown) were unable to generate LAK activity when incubated with fresh PBM . Atlhough IFN are known to augment suboptimal NK activity, as well as being produced in response to IL-2, we found them unable to directly convert noncytolytic LAK precursors into cytolytic cells active against NK-resistant tumors .
IL-2 was reported originally not to be stimulatory for nonactivated lymphocytes because in a 2-d [3H]thymidine-uptake assay, the stimulation is negligible relative to IL-2-dependent cells. Lectin-free IL-2 preparations, however, do cause detectable [3H]thymidine uptake above the level in control cultures and can be used to initiate long-term growth from these nonactivated populations (11, 12) . Direct activation of PBL into LAK cells by purified IL-2 suggests that receptors for IL-2 are expressed _on some PBL. Additional evidence for the existence of IL-2 receptors on PBL is suggested by the radiolabeled IL-2-binding studies of Robb et al . (7) in which a low number (-210/cell) of receptors was found on resting PBL .
The exact nature of the LAK precursor is still not understood . It was possible that the LAK precursors were the multiclonal memory T cells that may be circulating in the PBL, since it is known that secondary cytotoxic T lymphocytes (CTL) can be generated from memory T cells directly by IL-2 (5). However, the LAK precursors did not express the serologic phenotype of memory CTL, when tested in parallel with allospecific memory CTL generated in vitro (5) . TheseTesults imply that two subpopulations of PBL may respond directly to IL-2: the memory CTL, which express a T cell phenotype, and the LAK precursors, which do not. Summary Purified interleukin 2 (IL-2) was found to be sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer (LAK) cells. The LAK activation factor was directly and consistently associated with IL-2 activity 
